Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > $CXRX
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by CookieMonsteron May 27, 2016 2:35pm
76 Views
Post# 24911260

RE:RE:RE:$CXRX

RE:RE:RE:$CXRX I get around a 8 to 9% return assuming interest rates on debt stays the same.  That is @ $65 U.S.

Currently, CXR should generate $350 mln. Free cash flow and the market cap is $1.65 Bln. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities